Year archive

Simcere Pharmaceutical Group Limited — 2021 filings

All 71 regulatory filings released by Simcere Pharmaceutical Group Limited (S2P) in 2021, sourced directly from the official regulator.

71 Filings

2021 Period

2021 filings (71)

Filing	Released	Lang
VOLUNTARY ANNOUNCEMENT IN RELATION TO THE CLINICAL TRIAL APPROVAL FOR SIM0270 ISSUED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2021-12-28	English
CONTINUING CONNECTED TRANSACTIONS Regulatory Filings	2021-12-23	English
GRANT OF AWARDS AND ISSUE OF NEW SHARES UNDER THE 2021 RSU SCHEME Regulatory Filings	2021-12-23	English
VOLUNTARY ANNOUNCEMENT IN RELATION TO THE INCLUSION OF TRILACICLIB FOR INJECTION AS A PRIORITY REVIEW DRUG BY CDE Regulatory Filings	2021-12-22	English
VOLUNTARY ANNOUNCEMENT IN RELATION TO STRATEGIC COOPERATION WITH AVILEX TO INTRODUCE INNOVATIVE DIMERIC PSD-95 INHIBITOR Regulatory Filings	2021-12-14	English
VOLUNTARY ANNOUNCEMENT IN RELATION TO THE CLINICAL TRIAL APPROVAL FOR SIM0235 ISSUED BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2021-12-07	English
VOLUNTARY ANNOUNCEMENT IN RELATION TO THE CLINICAL TRIAL APPROVAL FOR SIM0395 (PAXALISIB) ISSUED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2021-12-07	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2021 Regulatory Filings	2021-12-06	English
VOLUNTARY ANNOUNCEMENT IN RELATION TO THE ACCEPTANCE OF MARKETING AUTHORIZATION APPLICATION FOR TRILACICLIB FOR INJECTION BY THE NMPA Regulatory Filings	2021-11-29	English
CONDITIONAL APPROVAL ON THE MARKETING OF ENWEIDA (ENVAFOLIMAB) IN CHINA BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2021-11-25	English
UNUSUAL PRICE AND TRADING VOLUME MOVEMENTS Regulatory Filings	2021-11-18	English
Next Day Disclosure Return Regulatory Filings	2021-11-12	English
COMPLETION OF ISSUE OF NEW SHARES UNDER THE 2021 RSU SCHEME Regulatory Filings	2021-11-12	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2021 Regulatory Filings	2021-11-02	English
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON NOVEMBER 1, 2021 Regulatory Filings	2021-11-01	English
Notification Letter and Request Form to Non-registered Shareholders Regulatory Filings	2021-10-11	English
PROXY FORM FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON NOVEMBER 1, 2021 Regulatory Filings	2021-10-11	English
NOTICE OF EXTRAORDINARY GENERAL MEETING Regulatory Filings	2021-10-11	English
CONNECTED TRANSACTIONS IN RELATION TO THE PROPOSED GRANT OF RSUS TO THE CONNECTED GRANTEES AND NOTICE OF EXTRAORDINARY GENERAL MEETING Regulatory Filings	2021-10-11	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2021 Regulatory Filings	2021-10-05	English
FURTHER DELAY IN DESPATCH OF CIRCULAR IN RELATION TO THE PROPOSED GRANT OF RSUS TO THE CONNECTED GRANTEES Regulatory Filings	2021-09-30	English
Notification Letter and Request Form to Non-registered Shareholders Regulatory Filings	2021-09-27	English
INTERIM REPORT 2021 Regulatory Filings	2021-09-27	English
DELAY IN DESPATCH OF CIRCULAR IN RELATION TO THE PROPOSED GRANT OF RSUS TO THE CONNECTED GRANTEES Regulatory Filings	2021-09-14	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2021 Regulatory Filings	2021-09-03	English
CONNECTED TRANSACTIONS IN RELATION TO THE PROPOSED GRANT OF RSUS TO THE CONNECTED GRANTEES Regulatory Filings	2021-08-27	English
VOLUNTARY ANNOUNCEMENT SHARE REPURCHASE Regulatory Filings	2021-08-26	English
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2021 Regulatory Filings	2021-08-26	English
DATE OF BOARD MEETING Regulatory Filings	2021-08-16	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2021 Regulatory Filings	2021-08-04	English
PROFIT ALERT Regulatory Filings	2021-08-02	English
VOLUNTARY ANNOUNCEMENT IN RELATION TO THE APPROVAL ON CLINICAL TRIAL APPLICATION FOR ENVAFOLIMAB IN COMBINATION WITH SEVACIZUMAB Regulatory Filings	2021-07-30	English
Next Day Disclosure Return Regulatory Filings	2021-07-28	English
COMPLETION OF ISSUE OF NEW SHARES UNDER THE 2021 RSU SCHEME Regulatory Filings	2021-07-28	English
GRANT OF AWARDS AND ISSUE OF NEW SHARES UNDER THE 2021 RSU SCHEME Regulatory Filings	2021-07-16	English
WAIVER FROM STRICT COMPLIANCE WITH RULES 3.28 AND 8.17 OF THE LISTING RULES Regulatory Filings	2021-07-12	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2021 Regulatory Filings	2021-07-07	English
RESIGNATION OF JOINT COMPANY SECRETARY Regulatory Filings	2021-06-30	English
VOLUNTARY ANNOUNCEMENT IN RELATION TO STRATEGIC REGIONAL LICENSING PARTNERSHIP ON THE DEVELOPMENT AND COMMERCIALIZATION OF N3pE AMYLOID-TARGETING MEDICINES TO TREAT ALZHEIMER'S DISEASE IN GREATER Regulatory Filings	2021-06-29	English
(I) POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON JUNE 25, 2021 AND (II) PAYMENT OF FINAL DIVIDEND Regulatory Filings	2021-06-25	English
VOLUNTARY ANNOUNCEMENT IN RELATION TO THE APPROVAL ON CLINICAL TRIAL APPLICATION FOR LENVATINIB IN COMBINATION WITH ENVAFOLIMAB Regulatory Filings	2021-06-17	English
VOLUNTARY ANNOUNCEMENT IN RELATION TO THE APPROVAL ON CLINICAL TRIAL APPLICATION FOR THE ADDITION OF NEW INDICATIONS OF TRILACICLIB FOR INJECTION Regulatory Filings	2021-06-14	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2021 Regulatory Filings	2021-06-04	English
Notification Letter and Request Form to Non-registered Shareholders Regulatory Filings	2021-05-25	English
PROXY FORM FOR ANNUAL GENERAL MEETING Regulatory Filings	2021-05-25	English
NOTICE OF ANNUAL GENERAL MEETING Regulatory Filings	2021-05-25	English
(I) PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE AND TO REPURCHASE SHARES; (II) PROPOSED RE-ELECTION OF RETIRING DIRECTORS; (III) PROPOSED DECLARATION AND PAYMENT OF FINAL DIVIDEND AND (IV Regulatory Filings	2021-05-25	English
ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2020 Regulatory Filings	2021-05-25	English
ADOPTION OF THE 2021 RSU SCHEME Regulatory Filings	2021-05-21	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2021 Regulatory Filings	2021-05-06	English
FURTHER ANNOUNCEMENT PROFIT FORECAST IN RELATION TO DISPOSAL OF SUBSIDIARIES Regulatory Filings	2021-04-28	English
NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED HOLDERS: NOTICE OF PUBLICATION OF 2020 ANNUAL REPORT Regulatory Filings	2021-04-26	English
ANNUAL REPORT 2020 Regulatory Filings	2021-04-26	English
VOLUNTARY ANNOUNCEMENT IN RELATION TO THE APPROVAL ON CLINICAL TRIAL APPLICATION FOR THE ADDITION OF NEW INDICATIONS OF TRILACICLIB FOR INJECTION Regulatory Filings	2021-04-16	English
CHANGE IN USE OF PROCEEDS Regulatory Filings	2021-04-15	English
CONNECTED TRANSACTION IN RELATION TO DISPOSAL OF SUBSIDIARIES Regulatory Filings	2021-04-15	English
VOLUNTARY ANNOUNCEMENT IN RELATION TO THE CLINICAL TRIAL APPROVAL FOR SIM-307 ISSUED BY THE CENTER FOR DRUG EVALUATION OF NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF PRC Regulatory Filings	2021-04-14	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2021 Regulatory Filings	2021-04-07	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Regulatory Filings	2021-03-31	English
RESIGNATION OF EXECUTIVE DIRECTOR AND CHIEF OPERATING OFFICER Regulatory Filings	2021-03-31	English
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2020 Regulatory Filings	2021-03-25	English
Revised Terms of Reference of the Strategy Committee Regulatory Filings	2021-03-25	English
VOLUNTARY ANNOUNCEMENT IN RELATION TO THE APPROVAL OF PHASE III CLINICAL TRIAL APPLICATION FOR ADDITION OF NEW INDICATION FOR ENDOSTAR BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF CHINA Regulatory Filings	2021-03-21	English
DATE OF BOARD MEETING Regulatory Filings	2021-03-15	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2021 Regulatory Filings	2021-03-02	English
VOLUNTARY ANNOUNCEMENT IN RELATION TO THE PUBLICATION OF CLINICAL STUDY DATA FOR SANBEXIN (EDARAVONE AND DEXBORNEOL CONCENTRATED SOLUTION FOR INJECTION) IN THE MEDICAL JOURNAL STROKE Regulatory Filings	2021-02-17	English
VOLUNTARY ANNOUNCEMENT Regulatory Filings	2021-02-15	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2021 Regulatory Filings	2021-02-03	English
INSIDE INFORMATION Regulatory Filings	2021-01-29	English
VOLUNTARY ANNOUNCEMENT IN RELATION TO THE CLINICAL TRIAL APPROVAL FOR TRILACICLIB FOR INJECTION ISSUED BY THE CENTER FOR DRUG EVALUATION OF NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF PRC Regulatory Filings	2021-01-20	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2020 Regulatory Filings	2021-01-06	English